CA1103684A - Process for preparing 2-thio-2-substituted-alkanoic acid derivatives - Google Patents
Process for preparing 2-thio-2-substituted-alkanoic acid derivativesInfo
- Publication number
- CA1103684A CA1103684A CA309,676A CA309676A CA1103684A CA 1103684 A CA1103684 A CA 1103684A CA 309676 A CA309676 A CA 309676A CA 1103684 A CA1103684 A CA 1103684A
- Authority
- CA
- Canada
- Prior art keywords
- formula
- group
- substituted
- carbon atoms
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002253 acid Substances 0.000 title claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 56
- -1 substituted-phenyl group Chemical group 0.000 claims abstract description 51
- 238000000034 method Methods 0.000 claims abstract description 50
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 36
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 34
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 31
- 125000005843 halogen group Chemical group 0.000 claims abstract description 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 14
- 239000002168 alkylating agent Substances 0.000 claims abstract description 12
- 229940100198 alkylating agent Drugs 0.000 claims abstract description 12
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims abstract description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 8
- 125000005037 alkyl phenyl group Chemical group 0.000 claims abstract description 6
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims abstract description 6
- 230000032050 esterification Effects 0.000 claims abstract description 6
- 238000005886 esterification reaction Methods 0.000 claims abstract description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 6
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims abstract description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 5
- 125000001424 substituent group Chemical group 0.000 claims abstract description 4
- 239000002904 solvent Substances 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 101100006371 Arabidopsis thaliana CHX3 gene Proteins 0.000 claims description 6
- 230000002152 alkylating effect Effects 0.000 claims description 6
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract description 4
- 230000003389 potentiating effect Effects 0.000 abstract description 3
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract description 2
- 239000002260 anti-inflammatory agent Substances 0.000 abstract description 2
- 229940083761 high-ceiling diuretics pyrazolone derivative Drugs 0.000 abstract description 2
- 229960000905 indomethacin Drugs 0.000 abstract description 2
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 abstract description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 229960004889 salicylic acid Drugs 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 40
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 27
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 24
- 239000000203 mixture Substances 0.000 description 23
- 239000000243 solution Substances 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 18
- 239000002585 base Substances 0.000 description 17
- 238000003756 stirring Methods 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 238000010898 silica gel chromatography Methods 0.000 description 11
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 9
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 238000010992 reflux Methods 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 8
- 230000002378 acidificating effect Effects 0.000 description 7
- 150000001299 aldehydes Chemical class 0.000 description 7
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 238000006722 reduction reaction Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- DIKBFYAXUHHXCS-UHFFFAOYSA-N bromoform Chemical compound BrC(Br)Br DIKBFYAXUHHXCS-UHFFFAOYSA-N 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- GEERKXVSWNZEQS-UHFFFAOYSA-N 2-(3-phenoxyphenyl)-2-phenylsulfanylacetic acid Chemical compound C=1C=CC(OC=2C=CC=CC=2)=CC=1C(C(=O)O)SC1=CC=CC=C1 GEERKXVSWNZEQS-UHFFFAOYSA-N 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 238000000862 absorption spectrum Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 235000011167 hydrochloric acid Nutrition 0.000 description 5
- 229960000443 hydrochloric acid Drugs 0.000 description 5
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- NLOLDUOUSDMWGN-UHFFFAOYSA-N 2-(3-phenoxyphenyl)-2-phenylsulfanylpropanoic acid Chemical compound C=1C=CC(OC=2C=CC=CC=2)=CC=1C(C)(C(O)=O)SC1=CC=CC=C1 NLOLDUOUSDMWGN-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 230000003301 hydrolyzing effect Effects 0.000 description 4
- CYWFCPPBTWOZSF-UHFFFAOYSA-N ibufenac Chemical compound CC(C)CC1=CC=C(CC(O)=O)C=C1 CYWFCPPBTWOZSF-UHFFFAOYSA-N 0.000 description 4
- 229950009183 ibufenac Drugs 0.000 description 4
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(3+);trinitrate Chemical compound [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 description 4
- KXUHSQYYJYAXGZ-UHFFFAOYSA-N isobutylbenzene Chemical compound CC(C)CC1=CC=CC=C1 KXUHSQYYJYAXGZ-UHFFFAOYSA-N 0.000 description 4
- 239000002798 polar solvent Substances 0.000 description 4
- 235000019260 propionic acid Nutrition 0.000 description 4
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- MRLGCTNJRREZHZ-UHFFFAOYSA-N 3-phenoxybenzaldehyde Chemical compound O=CC1=CC=CC(OC=2C=CC=CC=2)=C1 MRLGCTNJRREZHZ-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 3
- 150000008062 acetophenones Chemical class 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 229950005228 bromoform Drugs 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000001103 continuous-wave nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000005262 decarbonization Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- FZCDBGYCFVKRDV-UHFFFAOYSA-N 1-(3-phenoxyphenyl)ethanone Chemical compound CC(=O)C1=CC=CC(OC=2C=CC=CC=2)=C1 FZCDBGYCFVKRDV-UHFFFAOYSA-N 0.000 description 2
- FVBSOBQMQOBCRU-UHFFFAOYSA-N 2,2,2-trichloro-1-[4-(2-methylpropyl)phenyl]ethanol Chemical compound ClC(C(O)C1=CC=C(C=C1)CC(C)C)(Cl)Cl FVBSOBQMQOBCRU-UHFFFAOYSA-N 0.000 description 2
- QEYFYYSRHVDMNJ-UHFFFAOYSA-N 2-[4-(2-methylpropyl)phenyl]-2-phenylsulfanylacetic acid Chemical compound C1(=CC=CC=C1)SC(C(=O)O)C1=CC=C(C=C1)CC(C)C QEYFYYSRHVDMNJ-UHFFFAOYSA-N 0.000 description 2
- WKDHGFKPKDADCQ-UHFFFAOYSA-N 2-[4-(2-methylpropyl)phenyl]-2-phenylsulfanylpropanoic acid Chemical compound C1(=CC=CC=C1)SC(C(=O)O)(C)C1=CC=C(C=C1)CC(C)C WKDHGFKPKDADCQ-UHFFFAOYSA-N 0.000 description 2
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 2
- BDFAOUQQXJIZDG-UHFFFAOYSA-N 2-methylpropane-1-thiol Chemical compound CC(C)CS BDFAOUQQXJIZDG-UHFFFAOYSA-N 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- MLIREBYILWEBDM-UHFFFAOYSA-N anhydrous cyanoacetic acid Natural products OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- WQAQPCDUOCURKW-UHFFFAOYSA-N butanethiol Chemical compound CCCCS WQAQPCDUOCURKW-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 150000004651 carbonic acid esters Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- RDJGLLICXDHJDY-UHFFFAOYSA-N fenoprofen Chemical compound OC(=O)C(C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical class N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- HFFLGKNGCAIQMO-UHFFFAOYSA-N trichloroacetaldehyde Chemical compound ClC(Cl)(Cl)C=O HFFLGKNGCAIQMO-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- DBGSRZSKGVSXRK-UHFFFAOYSA-N 1-[2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]acetyl]-3,6-dihydro-2H-pyridine-4-carboxylic acid Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CCC(=CC1)C(=O)O DBGSRZSKGVSXRK-UHFFFAOYSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- DQGIAFGTEPJSDU-UHFFFAOYSA-N 2-(2-methylpropylsulfanyl)-2-(3-phenoxyphenyl)acetic acid Chemical compound CC(C)CSC(C(O)=O)C1=CC=CC(OC=2C=CC=CC=2)=C1 DQGIAFGTEPJSDU-UHFFFAOYSA-N 0.000 description 1
- LEMRHTTWKDVQEI-UHFFFAOYSA-N 2-(3-phenoxyphenyl)acetic acid Chemical class OC(=O)CC1=CC=CC(OC=2C=CC=CC=2)=C1 LEMRHTTWKDVQEI-UHFFFAOYSA-N 0.000 description 1
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- GATVIKZLVQHOMN-UHFFFAOYSA-N Chlorodibromomethane Chemical compound ClC(Br)Br GATVIKZLVQHOMN-UHFFFAOYSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005910 alkyl carbonate group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- FMWLUWPQPKEARP-UHFFFAOYSA-N bromodichloromethane Chemical compound ClC(Cl)Br FMWLUWPQPKEARP-UHFFFAOYSA-N 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- VRZVPALEJCLXPR-UHFFFAOYSA-N ethyl 4-methylbenzenesulfonate Chemical compound CCOS(=O)(=O)C1=CC=C(C)C=C1 VRZVPALEJCLXPR-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000004969 haloethyl group Chemical group 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- USXYVUYBWROVFR-UHFFFAOYSA-N methyl 2-(3-phenoxyphenyl)-2-phenylsulfanylpropanoate Chemical compound C=1C=CC(OC=2C=CC=CC=2)=CC=1C(C)(C(=O)OC)SC1=CC=CC=C1 USXYVUYBWROVFR-UHFFFAOYSA-N 0.000 description 1
- FUOQIQZCJJDBGD-UHFFFAOYSA-N methyl 2-(3-phenoxyphenyl)propanoate Chemical compound COC(=O)C(C)C1=CC=CC(OC=2C=CC=CC=2)=C1 FUOQIQZCJJDBGD-UHFFFAOYSA-N 0.000 description 1
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 230000002311 subsequent effect Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
Anti-inflammatory agents such as salicylic acid, pyra-zolone derivatives, indomethacin, etc. generally exhibit potent anti-inflammatory activity, but they also have serious side effects associated with them. The present invention provides a method of producing anti-inflammatory compounds not having as pronounced side effects. The compounds are 2-thio-2-substituted-alkanoic acid derivatives represented by the formula (I) (I) wherein A represents (1) a substituted-phenyl group of the formula in which y1 represents an isobutyl group or an unsubstituted-or substituted-phenoxy group wherein the substituent is a halogen atom, a trifluoromethyl group or an alkoxy group having 1 to 4 carbon atoms, or (2) a substituted-thienyl group of the formula in which y2 represents an alkyl group having 1 to 4 carbon atoms;
R represents an alkyl group having 1 to 4 carbon atoms; R3 represents a phenyl group, an alkyl-phenyl group wherein the alkyl group has 1 to 4 carbon atoms, or an alkyl group having 1 to 4 carbon atoms; and R4 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms The process comprises reacting a 2-(arylthio or alkylthio)-2-substituted-acetic acid of the formula (III)
Anti-inflammatory agents such as salicylic acid, pyra-zolone derivatives, indomethacin, etc. generally exhibit potent anti-inflammatory activity, but they also have serious side effects associated with them. The present invention provides a method of producing anti-inflammatory compounds not having as pronounced side effects. The compounds are 2-thio-2-substituted-alkanoic acid derivatives represented by the formula (I) (I) wherein A represents (1) a substituted-phenyl group of the formula in which y1 represents an isobutyl group or an unsubstituted-or substituted-phenoxy group wherein the substituent is a halogen atom, a trifluoromethyl group or an alkoxy group having 1 to 4 carbon atoms, or (2) a substituted-thienyl group of the formula in which y2 represents an alkyl group having 1 to 4 carbon atoms;
R represents an alkyl group having 1 to 4 carbon atoms; R3 represents a phenyl group, an alkyl-phenyl group wherein the alkyl group has 1 to 4 carbon atoms, or an alkyl group having 1 to 4 carbon atoms; and R4 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms The process comprises reacting a 2-(arylthio or alkylthio)-2-substituted-acetic acid of the formula (III)
Description
8~
1 This invention relates to a process for preparing
1 This invention relates to a process for preparing
2-thio-2-substituted-alkanoic acid derivatives represented by the formula (I) A - - f _ COOR (I) SR
wherein A represents (1) a substituted-phenyl group of the formula yl ~
in which yl represents an isobutyl group or an unsubstituted-or substituted-phenoxy group wherein the substituent is a halogen atom, a trifluoromethyl group or an alkoxy group having 1 to 4 carbon atoms, or (2) a substituted-thienyl group of the formula y2 S
in which Y represents an alkyl group having 1 to 4 carbon atoms;
R represents an alkyl group having 1 to 4 carbon atoms; R3 represents a phenyl group, an alkylphenyl group wherein the alkyl group has 1 to 4 carbon atoms, or an alkyl group having 1 to 4 carbon atoms; and R4 represents a hydrogen atom or an alkyl group having 1 to 4 c~rbon atomsi which are useful as intermed-iates for the synthesis of various pharmaceutical agents.
Hitherto, salicyclic acid derivatives, pyrazolone derivatives, indomethacin, etc. have been used widely as anti-inflammatory agents. These agents generally exhibit a potent anti-inflammatory activity, but they are also ~nown to cause serious side~effects such as gastro-intestinal disorders, adverse affects on hematosis, etc. upon administration.
Recently, various alkanoic acid derivatives such as 11~68~
1 2-(4-isobutylphenyl?propionic acid, 4-isobutylphenylacetic acid and 2-(3-phenoxyphenyl)alkanoic acid derivatives have been interesting because of their low possibility of causing side-effects, while the anti-inflammatory activity thereof is not so potent, thereby making it possible to administer these agents over a prolonged period of time to patients.
The compounds of the formula (I) above wherein A
represents a 4-isobutylphenyl group and a 3-phenoxyphenyl group can be easily converted into the above 2-(4-isobutylphenyl) propionic acid and 4-isobutylphenylacetic acid or a 2-(3-phenoxy-phenyl)alkanoic acid derivative. Also, the compound o~ the formula (I) wherein A represents a substituted-thienyl group can be easily converted, upon reduction, into an ~-(2-thienyl) alkanoic acid which can then be converted into thiobrophenic acid having an anti-inflammatory activity, as disclosed in Japanese Patent Publication (Examined) No. 24915/74. ~urther, some esters of the above ~-(2-thienyl)alkanoic acid are known to have a high insecticidal activity, as disclosed in Japanese Patent Publication (Unexamined~No. 126826/74.
Typical conventional processes for preparing 2-(phenoxy-phenyl)alkanoic acid derivatives represented by the formula (I) wherein A represents a substitued-phenyl group includes (1) a process comprising heat-refluxing a 3-phenoxyacetophenone deriva-tive with sulfur in the presence of a secondary amine to produce a 3-phenoxyphenylacetic acid derivative, condensing the resulting compound with a carbonic acid ester to form an arylmalonic acid ester, introducing an alkyl group into the ester, followed by hydrolysis and decarbonization to obtain the desired compound, as disclosed in Japanese Patent Publication (Examined) No. 45586/76;
(2) a process comprising converting a 3-phenoxy-halobenzyl deriva-1 tive as a starting material into a corresponding cyano compound,then into an alkoxycarbonyl compound, and alkylating, hydrolyzing and decarbonizing the resulting compound in the same manner as described for the process (1) above to obtain the desired compound, as disclosed in Japanese Patent Publication (Examined) No.
45586/76; (3) a process comprising reducing a 3-phenoxyaceto-phenone derivative followed by halogenation to ohtain a 1-(3-phenoxyphenyl)haloethyl, and converting the resulting compound into a corresponding nitrile derivative and then hydrolyzing the nitrile derivative, as disclosed in Japanese Patent Publication (Examined) No. 70744/76; and (4) a process comprising converting the l-(3-phenoxyphenyl)-haloethyl used in the above process (3) into a Grignard compound and reacting the Grignard compound with carbon dioxide to produce the desired compound, as disclosed in ~apanese Patent PublicatiOn (Unexamined) No. 65729/76.
However, the above conventional processes are not considered advantageous in the production on an industrial scale for the reasons that these processes require a number of reaction steps to produce the desired compounds; the starting material, an acetophenone derivative, used in the processes (1), (3) and (4) is not easily available as an industrial raw material; a highly toxic hydrocyanic acid derivative must be used as a reagent in the processes (2) and (3); and an absolutely anhydrous condi-tion must be used in preparing the Grignard compound in the process (4).
Also, typical conventional processes for preparing CX -(2-thienyl)alkanoic acid derivatives of the formula (I) wherein A represents a substituted-thienyl group include (1) a process comprising alkylating an Cr-(2-thienyl)cyanoacetic acid ester, followed by decarbonization to produce an ~ -(2-thienyl)-il~)3684 alkanenitrile and then hydrolyzing the nitrile group, as disclosedin M. Bercot-Vatteroni, R.C. Moreau and P. Reynaud Bull. Soc.
Chim., France, 1820 (1961); and (2) a process comprising condens-ing a thiophene with ethyl chloroglyoxarate, and reacting the resulting condensate with a Grignard compound followed by reduc-tion, as disclosed in F. Climence, 0. LeLartret, R. Fournex, G. Plassard and M. ~anaux, Eur. J. Med. Chem., (1974-9), 390.
However, these processes require a number of complicated reaction steps and therefore cannot be applied to the production 10 on an industrial scale.
Further, typical conventional processes for preparing 2-isobutylphenylalkanoic acid compounds of the formula (I) wherein A represents an isobutyl-substituted phenyl group include, for example, (1) a process comprising reacting a 4-isobutylphenyl-acetic acid ester with an alkyl carbonate in the presence of a base to produce a malonic acid ester compound, reacting the resulting compound with methyl iodide to alkylate the compound, followed by hydrolysis and de^arbonization, as disclosed in Japanese Patent Publication ~Examined) No. 7491/65 (2) a process 20 comprising reacting a 4-isobutylbenzylcyanamide with a carbonic acid ester in the presence of a base to form a cyanoacetic acid ester, and methylating the ester, followed by hydrolysis and decarbonization, as disclosed in Japanese Patent Publication (Unexamined~ No. 46037/77; (3) a process comprising alkylating a substituted-phenylacetanitrile in a polar solvent in the presence of an al}cali metal hydroxide, followed by hydrolysis, as disclosed in Japanese Patent Publication (Unexamined) No. 146433~76; (4~
a process comprising converting a l-(4-isobutylphenyl)-haloethyl into a Grignard compound and reacting the Grignard compound with 30 carbon dioxide, as disclosed in Japanese Patent Publication i~L533684 1 (Unexamined) No. 39050/74; (5) a process comprising reacting an acetophenone derivative with an alkali metal cyanade and ammonium carbonate to form hydantoin, hydrolyzing the resulting hvaantoin to produce an ~-amino acid, followed by alkylation and reduction to obtain ~-phenylpropionic acid, as disclosed in Japanese Patent Publication (Unexamined) No. 18105/72; and (6) a process comprising reacting an acetophenone derivative with an ~-halo-acetic acid ester in the presence of a base to form a glycidic acid ester, decarbonizing the resulting ester to form an aldehyde followed by oxidation, as disclosed in Japanese Patent Publication (Unexamined) No. 24550/72.
However, the above conventianal processes are not advantageous for the reasons that they require a number of reac-tion steps and, in addition, highly toxic hydrocyanic acid compounds are used in the processes (2), (3) and (5) either for preparing starting nitrile compound or as a reactant; an absolutely anhydrous condition must be used in preparing the Grigna^d compound used in the process (4); and the process (6) requires very critical oxidation conditions which are very difficult to be controlled.
As a result of extensive studies on the process for preparing the compounds of the formula (I) which can easily be converted into the corresponding 2-substituted-alkanoic acid compounds, the present inventors established a process for pre-paring the compounds of the formula (I) starting with easily available compounds through 3 to 4 reaction steps which can be relatively easily performed.
That is, the present invention provides a process for preparing 2-thio-2-substituted-alkanoic acid derivatives repre-sented by the formula (I) 1~33684 A C COOR (I) SR3wherein A represents (1) a substituted-phenyl group of the formula in which yl represents an isobutyl group or an unsubstituted-or substituted-phenoxy group wherein the substituent is a halogen atom, a trifluoromethyl group or an alkoxy group having 1 to 4 carbon atoms, or (2) a substituted-thienyl group of the formula y2~
S' in which y2 represents an alkyl group having lto 4 carbon atoms;
R represents an alkyl group having 1 to 4 carbon atoms; R3 rep-resents a phenyl group, an alkylphenyl group wherein the alkyl group has 1 to 4 carbon atoms, or an alkyl group having 1 to 4 - carbon atoms; and R4 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, which comprises condensing an - aldehyde compound of the formula (V) A--CH0 (V3 wherein A is as defined above, with a haloform of the formula CHX3 wherein X represents a halogen atom and a mercaptan com-pound of the formula (IV) ~3SH (IV) wherein R is as defined above, in the presence of a base to produce a 2-(arylthio or alkylthio)-2-substituted-acetic acid of the formula (III) A - fH- COOH (III) S~3 wherein A and R3 are as defined above, and reacting the resulting lfi;'~)3~84 1 2-(arylthio or alkylthio)-2-substituted-acetic acid with an alkylating agent represented by the formula (II) RZ (II) wherein R is as defined above, and Z represents a ~logen atom, an alkyl- or arylsulfonyloxy group or a sulfuric acid ester residual group, in the presence of at least 2 mols of a base per mol of the 2-(arylthio or alkylthio)-2-substituted acetic acid, to form the compound of the formula (I) wherein R4 represents a hydrogen atom, and optionally converting the resulting compound to the compound of the formula (I) wherein R4 represents an alkyl group by esterification.
The process according to the present invention can ke illustrated by the followina reaction scheme:
A -CHO (V) First Step ¦R3SH (IV) ~¦CHX3 A- CH-COOH (III) Second Step ¦RZ (II) R
A - C - COOR (I) wherein A, R R3 and R are as defined above, and X represents a halogen atom and Z represents a halogen atom, and al~yl or arylsulfonyloxy group or a sulfuric acid ester residual group.
First Step The first step of the process of this invention comprises condensing an aldehyde derivative of the formula (V) with a halo~orm of the formula CHX3 wherein X is as defined above and a mercaptan compound of the formula (IV) in the pre-sence of a base.
-7~
1~3684 1 Examples of the base which can be used in the above condensation reaction are alkali metal h~droxides such as sodium hydroxide, potassium hydroxide and the like, alkali metal alkox-ides such as sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide and the like, with sodium or potassium hydroxide being preferred from the economical stand-point. These bases are generally used in an amount of from about 4 to about 10 mols, preferably 5 to 6 mols, per mol of the aldehyde derivative of the formula (V).
Examples of the haloform of the formula CHX3 are chloroform, bromoform, monobromodichloromethane, monochloro-dibromomethane and the like. Particularly preferred haloforms are chloroform and bromoform. These haloforms can be used in an amount of from about 1 to about 5 mols, preferably 1.5 to 2 mols, per mol of the aldehyde derivative of the formula (V).
Examples of the mercaptan com~ounds of the formula (IV) are thiophenol, alkylphenyl mercaptans such as tolyl mercaptan, alkyl mercaptans such as methyl mercaptan, ethyl mercaptan, butyl mercaptan and the like. These mercaptans can be used in an amount of from about 1 to about 3 mols, preferably 1.5 to 2 mols, per mol of the aldehyde derivative of the formula (V).
In carrying out the first step of the process of this invention, a solvent can be preferably used. Typical exam~les of the solvents which can be used are polar solvents such as water, alcohols such as methanol, ethanol and the like, dimethyl sulfoxide, dimethylformamide and the like. Preferred solvents are protonic solvents such as water, methanol, ethanol, etc.
because of their high solubility of the base used in the reaction.
The reaction can be generally conducted at a temperature of about 0 to about 100C, preferably from room temperature (about 1~3684 1 15 to about 30C) to a refluXing temperature of the solvent used.
The reaction time varies depending upon the reaction temperature used, but is usually for about 1 to about 30 hours.
In the above condensation, the desired intermediate, 2-(arylthio or alkylthio)-2-substituted-acetic acids of the formula (III) can be obtained in high yield. The resulting intermediate of the formula (III) can be used in the subsequent step after it is isolated from the reaction mixture and purified by conventional procedures, for example, concentration of the reactiOn mixture, extraction with a solvent and then silica gel column chromatography, etc., or the reaction mixture per se obtained by the condensation reaction can be used in the sub-sequent step.
Second Step The second step comprises reacting the 2-(arylthio or alkylthio)-2-substituted-acetic acid of the formula (III) obtained in the above First ~tep with an alkylating agent of the formula (II) in the presence of at least 2 mols, preferably 2 to 3 mols, of a base per mol of the compound of the formula (III).
Examples of alkylating agents used in the above reaction are methyl iodide, methyl bromide, ethyl bromide, dimethylsulfuric acid, diethylsulfuric acid, methyl p-toluenesulfonate, ethyl p-toluenesulfonate, propyl bromide, isopropyl bromide, butyl bromide and the like. The alkylating agents are well known in the art as widely used in organic chemistry and can easily be available as industrial raw materials.
The alkylation reaction can preferably be carried out at a temperature of about -40 to room temperature for a period of about 1 to about 5 hours usinq an approximately equimolar to a slightly molar excess of alkylating agent, e.g., about 1.5 mol, per mol of the compound of the formula (III).
~ld33684 1 As described above, the reaction should be carried in the presence of at least 2 mols of a base per mol of the compound of the formula (III). In this reaction, 1 mol of the base is consumed in the formation of a carboxylic acid salt and the remaining 1 mol of the base is used for withdrawing the hydrogen atom at the CX-position of the carboxylic acid of the formula (III). In the dianion thus formed, an alkyl group is selectively introduced into the ~ -position of the dianion upon reaction with an alkylating agent because of a high reactivity of the C~ -position thereby forming the desired compound of the formula (I). `
Examples of bases which can be used in the second step are preferably strongly basic compounds such as sodium amide, potassium amide, butyl lithium, sodium hydride and the lïke.
In carrying out the reaction, a solvent is preferably used and examples of solvents are liquid ammonia, ethers such as diethyl ether, tetrahydrofuran and the like, non-protonic polar solvents such as dimethylformamide, dimethylsulfoxide and the like.
When sodium amide or potassium amide is used as a base, liquid ammonia is preferably used as a solvent, and when butyl lithium or sodium hydride is used as a base, an ether or a non-protonic polar solvent is preferably used.
In the above reaction, the desired compounds of the formula (I) wherein R represents a hydrogen atom can be obtained in high yield. These compounds can easily be converted into the corresponding esters wherein R4 represents an alkyl group by a conventional esterification procedure which is well known in the art.
In an alternative procedure, the compounds of the ~3~84 1 formula (III) wherein A represents a substituted-phenyl group yl ~ wherein yl represents an isobutyl group can also be prepared by reacting a 2,2,2-trihalo-1-(isobutylphenyl)-ethanol of the formula (V') _cx3 (V') 0~
wherein yl represents an isobutyl group and ~ represents a halo-gen atom, with a mercaptan compound of the formula (IV) in thepresence of a base. The reaction can be effected in the same manner using the same reaction parameters as described for the reaction of the first step, but without using the haloform of the formula CHX3.
The aldehyde derivatives of the formula (V) used as starting materials of the process of this invention are well known as described in J. Med. Chem. 15, 1297; Japanese Patent Puhlication (Unexamined) No. 95623/1977; and Org. Synth. Coll Vol. III, 811. Also, these aldehyde derivatives of the formula (V) can be easily prepared by either the Vilsmeier formulation reaction or the oxidation of the corresponding benzyl alcohol, as well known in the art.
The 2,2,2-trihalo-1-(isobutylphenyl)ethanol of the formula (V') used as a starting material in the alternative procedure for preparing the compound of the formula (III) can be easily prepared by reacting isobutylbenzene with a trihalo-acetoaldehyde, e.g., chloral, as described in Reference Example 5 hereinafter described.
As described previously, the compounds of the formula 3Q ~I) prepared in accordance with the process of this invention i~3684 1 can be converted into the corresponding ~-subsLituted-alkanoic acid of the formula (VI) 4 ~VI ) A-CH-CQOR
wherein A, R and R4 are as defined above, by reducing the com-pounds of the formula (I) as described in detail in Reference Examples hereinafter described. The reduction of the compounds of the formula (I) can be achieved by various methods which are well known in the art using, for example, zinc powder in a lower aliphatic acid, tin in a mineral acid, Raney nickel, sodium metal in a protonic solvent, etc. A particularly preferred reduction method is using zinc powder in a lower aliphatic acid such as acetic acid. In this manner, the compounds of the formula (IV), for example, a - (2-thienyl)alkanoic acid, 2-(4-isobutylphenyl)propionic acid, 4-isobutylphenylacetic acid and 2-(3-phenoxyphenyl)propionic acid can be obtained in almost quantitative yield.
If desired, the compounds of the formula (III) can be sub~ected to the above reduction procedure, before alkylation in the second step, to produce the corresponding acetic acid com-pounds of the formula (VI) wherein R represents a hydrogen atom.
As is apparent to one skilled in the art, one of the advantages of the process of this invention is that, in the reduction of the compounds of the formula (I) to produce the compounds of the formula (VI), an arylthio or alkylthio group -S~ is split out to form a mercaptan compound as a by-product.
Such mercaptan compound can be recovered for re-use in the first step of the process of this invention, whereby the process of this invention can be conducted econimically.
~0 The present invention is further illustrated by the ~ )3684 1 following Examples in greater detail, but they are given for illustrative purposes only and are not to be construed as limiting the present invention. Unless otherwise indicated, all parts, percents, ratios and the like are by weight.
Example 1 ~ mixture of 1.98 g (10 mmols) of 3-phenoxybenzalde-hyde, 1.65 g (15 mmols) of thiophenol, 1.79 g (15 mmols) of chloroform and 2 ml of ethanol was stirred at room temperature (about 15 to 30C), and 10 ml of an ethanolic solution of 2.8 g (S0 mmols) of potassium hydroxide was then added dropwise to the mixture while maintaining the temperature below 45C. The reaction mixture was further stirred for an additional one hour at 45C and then allowed to stand overnight at room temperatare While stirring. The reaction mixture was then poured into a mixture of 6N sulfuric acid and ice clump to render the mixture acidic and then saturated with sodium chloride. The saturated solution was then extracted with diethyl ether and the extract was concentrated. The resulting concentrate was then charged into a silica gel column, and the column was eluted first with benzene~hexane (1:1 by volume) and then with hexane-ethyl acetate (4:1 by volume). The combined eluate was concentrated to obtain 2.58 g (77~ yield) of 2-phenylthio-2-(3-phenoxyphenyl)acetic acid.
NMR (CC14)~ of Product: 4.68 (lH, s), 6.7 - 7.4 (14H, m), 11.6 (lH, bs).
Example 2 In the same manner as described in Example 1, but using a reaction temperature not exceeding 30C, 1.68 g (50% yield) of 2-phenylthio-2-(3-phenoxyphenyl)acetic acid was obtained.
Example 3 1.10 g of 3-phenoxybenzaldehyde, 1.65 g of thiophenol 11~) ~684 1 and 1.8 g of chloroform were dissolved in 5 ml of ethanol, and to the resulting solution was added dropwise a solution of 2.0 g of potassium hydroxide in 10 ml of ethanol over a period of 90 minutes. The reaction mixture was then stirred overnight at room temperature and then worked up in the same manner as de-scribed in Example 1 to obtain 1.10 g (65~ yield) of 2-phenylthio-2-(3-phenoxyphenyl)acetic acid.
Example 4 1.10 g (5 mmols) of 3-phenoxybenzaldehyde, 0.83 g (7.5 mmols) of thiophenol, 1.3 q (5.1 mmols) of bromoform, 1.7 g (26 mmols) of potassium hydroxide (having a purity higher than 85%) and 0.424 g (10 mmols) of lithium chloride were added to a mixture of 5 ml of dioxane and 5 g of ice clump, and the result-ing mixture was stirred vigorously for 5 hours at 0C and then 19 hours at room temperature. The reaction mixture was then diluted with water, rendered acidic with hydrochloric acid and extracted with methylene chloride. The extract was washed with water, dried over anhydrous magnesium sulfate and concentrated to remove the solvent to obtain a crude prodcut of 2-phenylthio-2-(3-phenoxyphenyl)acetic acid in a quantitative yield. The resultin~ crude product was purified by column chromatography eluting with hexane-diethyl ether (10:1 by volume) to obtain 1.54 g (92% yield) of the above product in a substantially pure form.
Example 5 In the same manner as described in Example 1, but using 1.35 g of isobutyl mercaptan in place of the thiophenol, 1.40 g (44g yield) of 2-isobutylthio-2-(3-phenoxyphenyl)acetic acid was obtained.
11~3684 1 NMR (CC14) ~ of Product: 0.93 (6H, d, J=7Hz), 1.62 (lH, m~, 2.40 (2H, d, J=7Hz), 4.53 (lH, s), 6.8 - 7.4 (9H, m).
Example 6 15 ml of liquid ammonia was charged into a 50 ml flask and 0.2 g (8.7 mmols) of sodium metal was dissolved therein in the presence of a catalytic amount of ferric nitrate thereby forming a liquid ammonia suspension of sodium amide. Thereafter, 1.22 g (3.63 mmols) of 2-phenylthio-2-(3-phenoxyphenyl)acetic acid prepared as described in Example 1 dissolved in 10 ml of diethyl ether was added dropwise to the above suspension of sodium amide. The reaction mixture was then stirred for 30 minutes at a temperature of -40C and a solution of 0.75 g (5.3 mmols) of methyl iodide in 5 ml of diethyl ether was added to the reaction mixture which was then stirred for further 30 minutes at -40C. The reaction mixture was then allowed to warm slowly by removing the cooling bath used and finally heated while refluxing for lS minutes to complete the reaction. 30 ml of water was added to the reaction mixture to dissolve any solid ~0 substances and the mixture was rendered acidic with lN hydro-chloric acid followed by being extracted with diethyl ether. The etherial extract was dried over anhydrous sodium sulfate and concentrated to obtain 1.23 g of a crude 2-phenylthio-2-(3-phenoxyphenyl)propionic acid. The resulting crude product was then purified by silica gel column chromatography eluting with diethyl ether-hexane (1-5 by volume) to obtain 1.10 g (87~ yield) of the above product in a substantially pure form.
NM~ (CC14~ ~ of Product: 1.76 (3H, s), 6.7-7.3 (14H, m).
Example 7 In the same manner as described in Example 6, but using 0.67 g of dimethylsulfuric acid in place of the methyl i~36S4 1 iodide, 2-phenylthio-2-(3-phenoxyphenyl)propionic acid was obtained in 83% yield.
Example 8 A portion of the product of Example 6, 2-phenylthio-2-(3-phenoxyphenyl)propionic acid, was esterified using diazomethane to obtain a corresponding methyl ester in a quanti-tative yield.
NMR (CC14) ~ of Product: 1.73 (3H, s), 3.68 (3H, s) 6.6-7.4 (14H, m).
Example 9 6.80 g (103 mmols) of potassium hydroxide (85% purity) was dissolved in 20 ml of methanol, and the resulting solution was added dropwise to a solution of 2.24 g (20.0 mmols) of thiophenealdehyde, 3.5 g (30.0 mmols) of chloroform and 3.30 g (30 mmols) of thiophenol in 10 ml of methanol over a period of 30 minutes at room temperature. The resulting reaction mixture was stirred at room temperature for 1 hour, and heated while refluxing for 1 hour. Most of the solvent was removed by distillation under reduced pressure, and the residue was dissolved in water. The solution was rendered acidic with hydro-chloric acid, and extracted with methylene chloride. The organic layer was dried over anhydrous magnesium sulfate and purified by silica gel column chromatography eluting with diethyl ether-hexane (1:5 by volume) to obtain 2.03 g (41% yield) of a -phenyl-thio-thiophene-2-acetic acid.
Example 10 0.69 g (30 milli atom) of sodium metal was added to 30 ml of liquid ammonia, and a catalytic amount of ferric nitrate was added to the solution followed by stirring at -40C until the blue color of the mixture disappeared. A solution of 2.52 g 1 (10.1 mmols) of cC-phenylthio-thiophene-2-acetic acid in 10 ml of diethyl ether was added dropwise to the above mixture, followed by stirring at -40C for 30 minutes. A solution of 2.80 g (19.7 mmols) of methyl iodide in 5 ml of diethyl ether was added dropwise thereto, and the reaction mixture was stirred for further 30 minutes at -40C. The cooling bath was removed and the mixture was then stirred overnight to remove ammonia. The resulting solid was then dissolved in water, and the solution was rendered acidic with hydrochlroic acid and extracted with methylene chloride. The extract was dried over anhydrous mag-nesium sulfate and the solvent was removed by distillation to obtain 2.61 g (98~ yield) of a crude product. The crude product thus obtained was then purified by silica gel column chroma-tography using a relatively short column eluting with diethyl ether-hexane (1:5 by volume) to obtain 2.55 g (98% yield) of C~-phenylthio-~ -(2-thiophene)propionic acid in a substantially pure form.
NMR (CC14)~ of Product: 1.87 (3H, s), 6.7-7.1 (8H, m), 11.85 (lH, s) Example 11 7.50 g (113.8 mmols~ of potassium hydroxide was dis-solved in 20 ml of methanol, and the solution was added dropwise to a solution of 2.24 g (20.0 mmols) of thiophenealdehyde, 4.78 ~ (40.0 mmols) of chloroform and 2.71 g (30.0 mmols) of t-butyl mexcaptan in 10 ml of methanol at room temperature over a period of 1 hour. After stirring for 16 hours at room tempera-ture, the mixture was diluted with water and washed with methylene chloride. The mixture was then rendered acidic with hydrochloric acid and extracted with methylene chloride. The extract was dried over anhydrous magnesium sulfate, concentrated 11~3684 1 and purified by silica gel column chromatography eluting with diethyl ether-hexane (1:5 by volume) to obtain 1.09 g (24% yield) Of CX-t-butylthio-~ (2-thiophene)acetic acid.
NMR (CC14) ~ of Product: 1.37 (9H, s), 4.67 (lH, s), 6.73-7.23 (3H, m), 11.37 (lH, bs).
Example 12 11.5 g (0.2 mol) of potassium hydroxide was dissolved in 70 ml of ethanol, and 6.5 g (57.6 mmols) of thiophenol was added thereto while cooling with ice and stirring. After 10 minutes, 10.8 g (38.4 mmols) of 2,2,2-trichloro-1-(4-isobutyl-phenyl)ethanol prepared as described in Reference Example 5 dissolved in 15 ml of ethanol was added to the above mixture followed by stirring at room temperature for 12 hours. The reaction mixture was rendered acidic with dilute hydrochloric acid, extracted with ethyl acetate. The organic layer was washed with a saturated aqueous solution of sodium chloride and dried over anhydrous magnesium sulfate. The solvent was removed by distillation and the resulting residue was purified by a silica gel column chromatography eluting with ethyl acetate-n-hexane (1:4 ~y volume) to obtain 8.5 g (74~ yield) of 2-phenylthio-2-(4-isobutylphenyl)acetic acid having a melting point of 92-95C
tafter recrystallized from n-hexane).
Infrared Absorption Spectrum (cm ): 3100-2500, 1690, 1280, 910, 730.
NMR (CC14) ~ of Product: 0.90 (d, J=6Hz, 6H), 1.67-2.07 (m, lH), 2.43 (d, J=6Hz, 2H), 4.70 (s, lH), 6.87-7.65 (m, 9H), 11.87 (s, lH).
Example 13 A catalytic amount of ferric chloride and 0.23 g (10 mmols) of sodium metal were added to 20 ml of liquid ammonia 1 to prepare a suspension of sodium amide. To the resulting suspension was then added a solution of 1 g (3.33 mmols) of 2-phenylthio-2-(4-isobutylphenyl)acetic acid dissolved in 12 ml of diethyl ether. After stirring the mixture at -40C for 1 hour, a solution of 0.71 g (5.0 mmols) of methyl iodide dissolved in 6 ml of diethyl ether was added to the mixture. After stirring the mixture at -40C for 3 hours, the mixture was allowed to warm slowly to room temperature and stirred for 15 minutes. The reactiOn mixture was decomposed with lN hydrochloric acid, and extracted with diethyl ether. The organic layer was washed with water and dried over anhydrous magnesium sulfate. The solvent was removed by distillation and the resulting residue was puri-fied by silica gel column chromatography eluting with ethyl acetate-n-hexane (1:4 by volume) to obtain 0.705 g (67% yield) of 2-phenylthio-2-(4-isobutylphenyl)propionic acid having a melting point of 76-79C (after recrystallized from n-hexane).
Infrared Absorption Spectrum (cm 1): 3100-2500, 1690, 1270, 920, 755, 695.
NMR Absorption Spectrum (CCl~)~ : 0.92 (d, J=6Hz, 6H), 1.77 ~s, 3Hj, 1.50-1.80 (m, lH), 2.43 (d, J=6Hz, 2H), 6.83-7.50 (m, 9H), 11.5 (broad s, lH).
Elementary Analysis:
Cal d for ClgH22O2S: C, 72.57; H, 7.05(%) Found : C, 72.42; H, 7.05(%).
~eference Example 1 330 mg of methyl 2-phenylthio-2-(3-phenoxyphenyl)-propionate obtained in Example 8 was dissolved in 2 ml of acetic acid and the solution was heated while refluxing for 1 hour in the presence of 300 mg of zinc powder. After allowing the ~q33684 1 reaction mixture to cool, it was diluted with ethyl acetate and the remaining zinc powder was removed by filtration. The fil-trate was concentrated to obtain methyl 2-(3-phenoxyphenyl)-propionate in a quantitative yield.
n26 1.5576.
NMR (CC14) ~ of Product: 1.43 (3H, d, J=7.5 Hz), 3.57 (lH, q, J=7.5 Hz), 3.63 (3H, s), 6.6-7.3 (9H, m).
~eference Exa~mple 2 .
1.11 g (3.17 mmols) of 2-phenylthio-2-(3-phenoxy-phenyl)propionic acid obtained in Example 6 was dissolved in 10 ml of acetic acid and the solution was heated while refluxing for 1 hour with stirring in the presence of 1.0 g of zinc powder.
The solid substance present in the reaction mixture was removed by filtration and washed with methylene chloride. The combined filtrate and washing was concentrated to obtain 0.86 g of a crude product which was then purified by silica gel column chromatography eluting with diethyl ether-hexane (1:5 by volume) to obtain 0.73 g (95% yield) of 2-(3-phenoxyphenyl)propionic acid. nD 1.5780.
NMR (CC14) ~ of Product: 1.48 (3H, d, J=7Hz), 3.62 (lH, q, J=7Hz), 6.6-7.6 (9H, m).
Reference Example 3 1.12 g (20 mmols) of potassium hydroxide was dissolved in 10 ml of methanol-in an argon atmosphere, and 0.6 g (5.45 mmols~ of thiophenol was added to the solution while stirring under cooling with water. After 10 minutes, a solution of 1.16 g (5 mmols) of ~ -trichloro-2-thiophenemethanol dissolved in 3 ml of methanol was added to the mixture. After lC minutes, the temperature of the mixture was gradually increased and then ~3684 1 heated under refluxing for 2 hours with vigorous stirring. The Mixture was then cooled to room temperature, and most of the solvent was removed by distillation under reduced pressure.
Diethyl ether was added to the residue and the mixture was decom-posed with dilute hydrochloric acid. The ether layer was separ-ated, washed with water, dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography eluting with ethyl acetate-n-hexane (1:4 by volume) to obtain 940 mg (76% yield) of ~-phenylthio-thiophene-2-acetic acid as a viscous oily substance.
Infrared Absorption Spectrum (cm 1) : 3060, 1715, 1587, 1485, 1440, 1416, 1253, 750, 705, 694.
NMR (CDC13) ~ : 5.03 (s, lH), 6.52-7.60 (m, 8H), 11.47 (s, lH).
Reference Example 4 2.34 g (8.85 mmols) of ~ -phenylthio-~-(2-thiophene)-propionic acid was dissolved in 20 ml of acetic acid, and 1.5 g of zinc powder was added thereto followed by heat-refluxing for 30 minutes. An additional 1.5 g of zinc powder was added thereto followed by heat-refluxing for further 1.5 hours. Most of the solvent was then removed under reduced pressure, and methylene chloride was added to the residue. The solution was then filtered through Celite to remove solid substance. The filtrate was then concentrated and purified by silica gel column chroma-tography eluting with diethyl ether-hexane (1:10 by volume) to obtain 1.28 g (92% yield) of ~ -(2-thiophene)propionic acid as a colorless oily substance.
NMR tCC14) ~ : 1.60 (3H, d, J=7Hz), 3.93 (lH, q, J=7Hz), 6.67-6.87 (2H, m), 7.07 (lH, m).
i~3684 1 Reference Example 5 .
17.7 g (0.12 mol) of chloral was dissolved in 90 ml of dichloromethane, and 11.4 g (60 mmols) of titanium tetrachloride was added to the solution in an argon atmosphere while cooling with ice and stirring. A solution of 8.05 g (60 mmols) of iso-butylbenzene dissolved in 8 ml of dichloromethane was added there-to and the temperature of the resulting mixture was increased slowly to room temperature followed by stirring for 5 hours. The reaction mixture was then again cooled with ice, decomposed with water and extracted with dichloromethane. The organic layer was washed with water, and dried over anhydrous magnesium sulfate.
Unreacted isobutylbenzene was recovered (3.6 g; Percent Recovery, 45~, Boiling Point, 65-64C/20 mmHg) to obtain 6.8 g (73~ yield based on isobutylbenzene) of 2,2,2-trichloro-1-(4-isobutyl-phenyl)ethanol having a boiling point of 115C/0.2 mmHg.
Infrared Absorption Spectrum (cm 1): 3420, 2950, 1610, 1510, 1060, 820.
NMR Absorption Spectrum (CC14) ~ : 0.93 (d, J=6.5 ~z, 6H ), 1.56-2.50 (m, lH), 2.50 (d, J=6.5Hz, 2H), 3.~8 (broad s, lH), 5.05 (s, lH), 6.97-7.47 (m, 4H).
Reference Example 6 0.3 g (0.955 mmol) of 2-phenylthio-2-(4-isobutyl-phenyl)propionic acid was dissolved in 6 ml of acetic acid, and 0.31 g (4.8 mmols) of zinc powder was added thereto followed by heating for 3 hours with stirring. The reaction was then filtered through Celite, and the filtrate was concentrated under reduced pressure. The concentrate was extracted with diethyl ether, and the organic layer was washed with water and dried over
wherein A represents (1) a substituted-phenyl group of the formula yl ~
in which yl represents an isobutyl group or an unsubstituted-or substituted-phenoxy group wherein the substituent is a halogen atom, a trifluoromethyl group or an alkoxy group having 1 to 4 carbon atoms, or (2) a substituted-thienyl group of the formula y2 S
in which Y represents an alkyl group having 1 to 4 carbon atoms;
R represents an alkyl group having 1 to 4 carbon atoms; R3 represents a phenyl group, an alkylphenyl group wherein the alkyl group has 1 to 4 carbon atoms, or an alkyl group having 1 to 4 carbon atoms; and R4 represents a hydrogen atom or an alkyl group having 1 to 4 c~rbon atomsi which are useful as intermed-iates for the synthesis of various pharmaceutical agents.
Hitherto, salicyclic acid derivatives, pyrazolone derivatives, indomethacin, etc. have been used widely as anti-inflammatory agents. These agents generally exhibit a potent anti-inflammatory activity, but they are also ~nown to cause serious side~effects such as gastro-intestinal disorders, adverse affects on hematosis, etc. upon administration.
Recently, various alkanoic acid derivatives such as 11~68~
1 2-(4-isobutylphenyl?propionic acid, 4-isobutylphenylacetic acid and 2-(3-phenoxyphenyl)alkanoic acid derivatives have been interesting because of their low possibility of causing side-effects, while the anti-inflammatory activity thereof is not so potent, thereby making it possible to administer these agents over a prolonged period of time to patients.
The compounds of the formula (I) above wherein A
represents a 4-isobutylphenyl group and a 3-phenoxyphenyl group can be easily converted into the above 2-(4-isobutylphenyl) propionic acid and 4-isobutylphenylacetic acid or a 2-(3-phenoxy-phenyl)alkanoic acid derivative. Also, the compound o~ the formula (I) wherein A represents a substituted-thienyl group can be easily converted, upon reduction, into an ~-(2-thienyl) alkanoic acid which can then be converted into thiobrophenic acid having an anti-inflammatory activity, as disclosed in Japanese Patent Publication (Examined) No. 24915/74. ~urther, some esters of the above ~-(2-thienyl)alkanoic acid are known to have a high insecticidal activity, as disclosed in Japanese Patent Publication (Unexamined~No. 126826/74.
Typical conventional processes for preparing 2-(phenoxy-phenyl)alkanoic acid derivatives represented by the formula (I) wherein A represents a substitued-phenyl group includes (1) a process comprising heat-refluxing a 3-phenoxyacetophenone deriva-tive with sulfur in the presence of a secondary amine to produce a 3-phenoxyphenylacetic acid derivative, condensing the resulting compound with a carbonic acid ester to form an arylmalonic acid ester, introducing an alkyl group into the ester, followed by hydrolysis and decarbonization to obtain the desired compound, as disclosed in Japanese Patent Publication (Examined) No. 45586/76;
(2) a process comprising converting a 3-phenoxy-halobenzyl deriva-1 tive as a starting material into a corresponding cyano compound,then into an alkoxycarbonyl compound, and alkylating, hydrolyzing and decarbonizing the resulting compound in the same manner as described for the process (1) above to obtain the desired compound, as disclosed in Japanese Patent Publication (Examined) No.
45586/76; (3) a process comprising reducing a 3-phenoxyaceto-phenone derivative followed by halogenation to ohtain a 1-(3-phenoxyphenyl)haloethyl, and converting the resulting compound into a corresponding nitrile derivative and then hydrolyzing the nitrile derivative, as disclosed in Japanese Patent Publication (Examined) No. 70744/76; and (4) a process comprising converting the l-(3-phenoxyphenyl)-haloethyl used in the above process (3) into a Grignard compound and reacting the Grignard compound with carbon dioxide to produce the desired compound, as disclosed in ~apanese Patent PublicatiOn (Unexamined) No. 65729/76.
However, the above conventional processes are not considered advantageous in the production on an industrial scale for the reasons that these processes require a number of reaction steps to produce the desired compounds; the starting material, an acetophenone derivative, used in the processes (1), (3) and (4) is not easily available as an industrial raw material; a highly toxic hydrocyanic acid derivative must be used as a reagent in the processes (2) and (3); and an absolutely anhydrous condi-tion must be used in preparing the Grignard compound in the process (4).
Also, typical conventional processes for preparing CX -(2-thienyl)alkanoic acid derivatives of the formula (I) wherein A represents a substituted-thienyl group include (1) a process comprising alkylating an Cr-(2-thienyl)cyanoacetic acid ester, followed by decarbonization to produce an ~ -(2-thienyl)-il~)3684 alkanenitrile and then hydrolyzing the nitrile group, as disclosedin M. Bercot-Vatteroni, R.C. Moreau and P. Reynaud Bull. Soc.
Chim., France, 1820 (1961); and (2) a process comprising condens-ing a thiophene with ethyl chloroglyoxarate, and reacting the resulting condensate with a Grignard compound followed by reduc-tion, as disclosed in F. Climence, 0. LeLartret, R. Fournex, G. Plassard and M. ~anaux, Eur. J. Med. Chem., (1974-9), 390.
However, these processes require a number of complicated reaction steps and therefore cannot be applied to the production 10 on an industrial scale.
Further, typical conventional processes for preparing 2-isobutylphenylalkanoic acid compounds of the formula (I) wherein A represents an isobutyl-substituted phenyl group include, for example, (1) a process comprising reacting a 4-isobutylphenyl-acetic acid ester with an alkyl carbonate in the presence of a base to produce a malonic acid ester compound, reacting the resulting compound with methyl iodide to alkylate the compound, followed by hydrolysis and de^arbonization, as disclosed in Japanese Patent Publication ~Examined) No. 7491/65 (2) a process 20 comprising reacting a 4-isobutylbenzylcyanamide with a carbonic acid ester in the presence of a base to form a cyanoacetic acid ester, and methylating the ester, followed by hydrolysis and decarbonization, as disclosed in Japanese Patent Publication (Unexamined~ No. 46037/77; (3) a process comprising alkylating a substituted-phenylacetanitrile in a polar solvent in the presence of an al}cali metal hydroxide, followed by hydrolysis, as disclosed in Japanese Patent Publication (Unexamined) No. 146433~76; (4~
a process comprising converting a l-(4-isobutylphenyl)-haloethyl into a Grignard compound and reacting the Grignard compound with 30 carbon dioxide, as disclosed in Japanese Patent Publication i~L533684 1 (Unexamined) No. 39050/74; (5) a process comprising reacting an acetophenone derivative with an alkali metal cyanade and ammonium carbonate to form hydantoin, hydrolyzing the resulting hvaantoin to produce an ~-amino acid, followed by alkylation and reduction to obtain ~-phenylpropionic acid, as disclosed in Japanese Patent Publication (Unexamined) No. 18105/72; and (6) a process comprising reacting an acetophenone derivative with an ~-halo-acetic acid ester in the presence of a base to form a glycidic acid ester, decarbonizing the resulting ester to form an aldehyde followed by oxidation, as disclosed in Japanese Patent Publication (Unexamined) No. 24550/72.
However, the above conventianal processes are not advantageous for the reasons that they require a number of reac-tion steps and, in addition, highly toxic hydrocyanic acid compounds are used in the processes (2), (3) and (5) either for preparing starting nitrile compound or as a reactant; an absolutely anhydrous condition must be used in preparing the Grigna^d compound used in the process (4); and the process (6) requires very critical oxidation conditions which are very difficult to be controlled.
As a result of extensive studies on the process for preparing the compounds of the formula (I) which can easily be converted into the corresponding 2-substituted-alkanoic acid compounds, the present inventors established a process for pre-paring the compounds of the formula (I) starting with easily available compounds through 3 to 4 reaction steps which can be relatively easily performed.
That is, the present invention provides a process for preparing 2-thio-2-substituted-alkanoic acid derivatives repre-sented by the formula (I) 1~33684 A C COOR (I) SR3wherein A represents (1) a substituted-phenyl group of the formula in which yl represents an isobutyl group or an unsubstituted-or substituted-phenoxy group wherein the substituent is a halogen atom, a trifluoromethyl group or an alkoxy group having 1 to 4 carbon atoms, or (2) a substituted-thienyl group of the formula y2~
S' in which y2 represents an alkyl group having lto 4 carbon atoms;
R represents an alkyl group having 1 to 4 carbon atoms; R3 rep-resents a phenyl group, an alkylphenyl group wherein the alkyl group has 1 to 4 carbon atoms, or an alkyl group having 1 to 4 - carbon atoms; and R4 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, which comprises condensing an - aldehyde compound of the formula (V) A--CH0 (V3 wherein A is as defined above, with a haloform of the formula CHX3 wherein X represents a halogen atom and a mercaptan com-pound of the formula (IV) ~3SH (IV) wherein R is as defined above, in the presence of a base to produce a 2-(arylthio or alkylthio)-2-substituted-acetic acid of the formula (III) A - fH- COOH (III) S~3 wherein A and R3 are as defined above, and reacting the resulting lfi;'~)3~84 1 2-(arylthio or alkylthio)-2-substituted-acetic acid with an alkylating agent represented by the formula (II) RZ (II) wherein R is as defined above, and Z represents a ~logen atom, an alkyl- or arylsulfonyloxy group or a sulfuric acid ester residual group, in the presence of at least 2 mols of a base per mol of the 2-(arylthio or alkylthio)-2-substituted acetic acid, to form the compound of the formula (I) wherein R4 represents a hydrogen atom, and optionally converting the resulting compound to the compound of the formula (I) wherein R4 represents an alkyl group by esterification.
The process according to the present invention can ke illustrated by the followina reaction scheme:
A -CHO (V) First Step ¦R3SH (IV) ~¦CHX3 A- CH-COOH (III) Second Step ¦RZ (II) R
A - C - COOR (I) wherein A, R R3 and R are as defined above, and X represents a halogen atom and Z represents a halogen atom, and al~yl or arylsulfonyloxy group or a sulfuric acid ester residual group.
First Step The first step of the process of this invention comprises condensing an aldehyde derivative of the formula (V) with a halo~orm of the formula CHX3 wherein X is as defined above and a mercaptan compound of the formula (IV) in the pre-sence of a base.
-7~
1~3684 1 Examples of the base which can be used in the above condensation reaction are alkali metal h~droxides such as sodium hydroxide, potassium hydroxide and the like, alkali metal alkox-ides such as sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide and the like, with sodium or potassium hydroxide being preferred from the economical stand-point. These bases are generally used in an amount of from about 4 to about 10 mols, preferably 5 to 6 mols, per mol of the aldehyde derivative of the formula (V).
Examples of the haloform of the formula CHX3 are chloroform, bromoform, monobromodichloromethane, monochloro-dibromomethane and the like. Particularly preferred haloforms are chloroform and bromoform. These haloforms can be used in an amount of from about 1 to about 5 mols, preferably 1.5 to 2 mols, per mol of the aldehyde derivative of the formula (V).
Examples of the mercaptan com~ounds of the formula (IV) are thiophenol, alkylphenyl mercaptans such as tolyl mercaptan, alkyl mercaptans such as methyl mercaptan, ethyl mercaptan, butyl mercaptan and the like. These mercaptans can be used in an amount of from about 1 to about 3 mols, preferably 1.5 to 2 mols, per mol of the aldehyde derivative of the formula (V).
In carrying out the first step of the process of this invention, a solvent can be preferably used. Typical exam~les of the solvents which can be used are polar solvents such as water, alcohols such as methanol, ethanol and the like, dimethyl sulfoxide, dimethylformamide and the like. Preferred solvents are protonic solvents such as water, methanol, ethanol, etc.
because of their high solubility of the base used in the reaction.
The reaction can be generally conducted at a temperature of about 0 to about 100C, preferably from room temperature (about 1~3684 1 15 to about 30C) to a refluXing temperature of the solvent used.
The reaction time varies depending upon the reaction temperature used, but is usually for about 1 to about 30 hours.
In the above condensation, the desired intermediate, 2-(arylthio or alkylthio)-2-substituted-acetic acids of the formula (III) can be obtained in high yield. The resulting intermediate of the formula (III) can be used in the subsequent step after it is isolated from the reaction mixture and purified by conventional procedures, for example, concentration of the reactiOn mixture, extraction with a solvent and then silica gel column chromatography, etc., or the reaction mixture per se obtained by the condensation reaction can be used in the sub-sequent step.
Second Step The second step comprises reacting the 2-(arylthio or alkylthio)-2-substituted-acetic acid of the formula (III) obtained in the above First ~tep with an alkylating agent of the formula (II) in the presence of at least 2 mols, preferably 2 to 3 mols, of a base per mol of the compound of the formula (III).
Examples of alkylating agents used in the above reaction are methyl iodide, methyl bromide, ethyl bromide, dimethylsulfuric acid, diethylsulfuric acid, methyl p-toluenesulfonate, ethyl p-toluenesulfonate, propyl bromide, isopropyl bromide, butyl bromide and the like. The alkylating agents are well known in the art as widely used in organic chemistry and can easily be available as industrial raw materials.
The alkylation reaction can preferably be carried out at a temperature of about -40 to room temperature for a period of about 1 to about 5 hours usinq an approximately equimolar to a slightly molar excess of alkylating agent, e.g., about 1.5 mol, per mol of the compound of the formula (III).
~ld33684 1 As described above, the reaction should be carried in the presence of at least 2 mols of a base per mol of the compound of the formula (III). In this reaction, 1 mol of the base is consumed in the formation of a carboxylic acid salt and the remaining 1 mol of the base is used for withdrawing the hydrogen atom at the CX-position of the carboxylic acid of the formula (III). In the dianion thus formed, an alkyl group is selectively introduced into the ~ -position of the dianion upon reaction with an alkylating agent because of a high reactivity of the C~ -position thereby forming the desired compound of the formula (I). `
Examples of bases which can be used in the second step are preferably strongly basic compounds such as sodium amide, potassium amide, butyl lithium, sodium hydride and the lïke.
In carrying out the reaction, a solvent is preferably used and examples of solvents are liquid ammonia, ethers such as diethyl ether, tetrahydrofuran and the like, non-protonic polar solvents such as dimethylformamide, dimethylsulfoxide and the like.
When sodium amide or potassium amide is used as a base, liquid ammonia is preferably used as a solvent, and when butyl lithium or sodium hydride is used as a base, an ether or a non-protonic polar solvent is preferably used.
In the above reaction, the desired compounds of the formula (I) wherein R represents a hydrogen atom can be obtained in high yield. These compounds can easily be converted into the corresponding esters wherein R4 represents an alkyl group by a conventional esterification procedure which is well known in the art.
In an alternative procedure, the compounds of the ~3~84 1 formula (III) wherein A represents a substituted-phenyl group yl ~ wherein yl represents an isobutyl group can also be prepared by reacting a 2,2,2-trihalo-1-(isobutylphenyl)-ethanol of the formula (V') _cx3 (V') 0~
wherein yl represents an isobutyl group and ~ represents a halo-gen atom, with a mercaptan compound of the formula (IV) in thepresence of a base. The reaction can be effected in the same manner using the same reaction parameters as described for the reaction of the first step, but without using the haloform of the formula CHX3.
The aldehyde derivatives of the formula (V) used as starting materials of the process of this invention are well known as described in J. Med. Chem. 15, 1297; Japanese Patent Puhlication (Unexamined) No. 95623/1977; and Org. Synth. Coll Vol. III, 811. Also, these aldehyde derivatives of the formula (V) can be easily prepared by either the Vilsmeier formulation reaction or the oxidation of the corresponding benzyl alcohol, as well known in the art.
The 2,2,2-trihalo-1-(isobutylphenyl)ethanol of the formula (V') used as a starting material in the alternative procedure for preparing the compound of the formula (III) can be easily prepared by reacting isobutylbenzene with a trihalo-acetoaldehyde, e.g., chloral, as described in Reference Example 5 hereinafter described.
As described previously, the compounds of the formula 3Q ~I) prepared in accordance with the process of this invention i~3684 1 can be converted into the corresponding ~-subsLituted-alkanoic acid of the formula (VI) 4 ~VI ) A-CH-CQOR
wherein A, R and R4 are as defined above, by reducing the com-pounds of the formula (I) as described in detail in Reference Examples hereinafter described. The reduction of the compounds of the formula (I) can be achieved by various methods which are well known in the art using, for example, zinc powder in a lower aliphatic acid, tin in a mineral acid, Raney nickel, sodium metal in a protonic solvent, etc. A particularly preferred reduction method is using zinc powder in a lower aliphatic acid such as acetic acid. In this manner, the compounds of the formula (IV), for example, a - (2-thienyl)alkanoic acid, 2-(4-isobutylphenyl)propionic acid, 4-isobutylphenylacetic acid and 2-(3-phenoxyphenyl)propionic acid can be obtained in almost quantitative yield.
If desired, the compounds of the formula (III) can be sub~ected to the above reduction procedure, before alkylation in the second step, to produce the corresponding acetic acid com-pounds of the formula (VI) wherein R represents a hydrogen atom.
As is apparent to one skilled in the art, one of the advantages of the process of this invention is that, in the reduction of the compounds of the formula (I) to produce the compounds of the formula (VI), an arylthio or alkylthio group -S~ is split out to form a mercaptan compound as a by-product.
Such mercaptan compound can be recovered for re-use in the first step of the process of this invention, whereby the process of this invention can be conducted econimically.
~0 The present invention is further illustrated by the ~ )3684 1 following Examples in greater detail, but they are given for illustrative purposes only and are not to be construed as limiting the present invention. Unless otherwise indicated, all parts, percents, ratios and the like are by weight.
Example 1 ~ mixture of 1.98 g (10 mmols) of 3-phenoxybenzalde-hyde, 1.65 g (15 mmols) of thiophenol, 1.79 g (15 mmols) of chloroform and 2 ml of ethanol was stirred at room temperature (about 15 to 30C), and 10 ml of an ethanolic solution of 2.8 g (S0 mmols) of potassium hydroxide was then added dropwise to the mixture while maintaining the temperature below 45C. The reaction mixture was further stirred for an additional one hour at 45C and then allowed to stand overnight at room temperatare While stirring. The reaction mixture was then poured into a mixture of 6N sulfuric acid and ice clump to render the mixture acidic and then saturated with sodium chloride. The saturated solution was then extracted with diethyl ether and the extract was concentrated. The resulting concentrate was then charged into a silica gel column, and the column was eluted first with benzene~hexane (1:1 by volume) and then with hexane-ethyl acetate (4:1 by volume). The combined eluate was concentrated to obtain 2.58 g (77~ yield) of 2-phenylthio-2-(3-phenoxyphenyl)acetic acid.
NMR (CC14)~ of Product: 4.68 (lH, s), 6.7 - 7.4 (14H, m), 11.6 (lH, bs).
Example 2 In the same manner as described in Example 1, but using a reaction temperature not exceeding 30C, 1.68 g (50% yield) of 2-phenylthio-2-(3-phenoxyphenyl)acetic acid was obtained.
Example 3 1.10 g of 3-phenoxybenzaldehyde, 1.65 g of thiophenol 11~) ~684 1 and 1.8 g of chloroform were dissolved in 5 ml of ethanol, and to the resulting solution was added dropwise a solution of 2.0 g of potassium hydroxide in 10 ml of ethanol over a period of 90 minutes. The reaction mixture was then stirred overnight at room temperature and then worked up in the same manner as de-scribed in Example 1 to obtain 1.10 g (65~ yield) of 2-phenylthio-2-(3-phenoxyphenyl)acetic acid.
Example 4 1.10 g (5 mmols) of 3-phenoxybenzaldehyde, 0.83 g (7.5 mmols) of thiophenol, 1.3 q (5.1 mmols) of bromoform, 1.7 g (26 mmols) of potassium hydroxide (having a purity higher than 85%) and 0.424 g (10 mmols) of lithium chloride were added to a mixture of 5 ml of dioxane and 5 g of ice clump, and the result-ing mixture was stirred vigorously for 5 hours at 0C and then 19 hours at room temperature. The reaction mixture was then diluted with water, rendered acidic with hydrochloric acid and extracted with methylene chloride. The extract was washed with water, dried over anhydrous magnesium sulfate and concentrated to remove the solvent to obtain a crude prodcut of 2-phenylthio-2-(3-phenoxyphenyl)acetic acid in a quantitative yield. The resultin~ crude product was purified by column chromatography eluting with hexane-diethyl ether (10:1 by volume) to obtain 1.54 g (92% yield) of the above product in a substantially pure form.
Example 5 In the same manner as described in Example 1, but using 1.35 g of isobutyl mercaptan in place of the thiophenol, 1.40 g (44g yield) of 2-isobutylthio-2-(3-phenoxyphenyl)acetic acid was obtained.
11~3684 1 NMR (CC14) ~ of Product: 0.93 (6H, d, J=7Hz), 1.62 (lH, m~, 2.40 (2H, d, J=7Hz), 4.53 (lH, s), 6.8 - 7.4 (9H, m).
Example 6 15 ml of liquid ammonia was charged into a 50 ml flask and 0.2 g (8.7 mmols) of sodium metal was dissolved therein in the presence of a catalytic amount of ferric nitrate thereby forming a liquid ammonia suspension of sodium amide. Thereafter, 1.22 g (3.63 mmols) of 2-phenylthio-2-(3-phenoxyphenyl)acetic acid prepared as described in Example 1 dissolved in 10 ml of diethyl ether was added dropwise to the above suspension of sodium amide. The reaction mixture was then stirred for 30 minutes at a temperature of -40C and a solution of 0.75 g (5.3 mmols) of methyl iodide in 5 ml of diethyl ether was added to the reaction mixture which was then stirred for further 30 minutes at -40C. The reaction mixture was then allowed to warm slowly by removing the cooling bath used and finally heated while refluxing for lS minutes to complete the reaction. 30 ml of water was added to the reaction mixture to dissolve any solid ~0 substances and the mixture was rendered acidic with lN hydro-chloric acid followed by being extracted with diethyl ether. The etherial extract was dried over anhydrous sodium sulfate and concentrated to obtain 1.23 g of a crude 2-phenylthio-2-(3-phenoxyphenyl)propionic acid. The resulting crude product was then purified by silica gel column chromatography eluting with diethyl ether-hexane (1-5 by volume) to obtain 1.10 g (87~ yield) of the above product in a substantially pure form.
NM~ (CC14~ ~ of Product: 1.76 (3H, s), 6.7-7.3 (14H, m).
Example 7 In the same manner as described in Example 6, but using 0.67 g of dimethylsulfuric acid in place of the methyl i~36S4 1 iodide, 2-phenylthio-2-(3-phenoxyphenyl)propionic acid was obtained in 83% yield.
Example 8 A portion of the product of Example 6, 2-phenylthio-2-(3-phenoxyphenyl)propionic acid, was esterified using diazomethane to obtain a corresponding methyl ester in a quanti-tative yield.
NMR (CC14) ~ of Product: 1.73 (3H, s), 3.68 (3H, s) 6.6-7.4 (14H, m).
Example 9 6.80 g (103 mmols) of potassium hydroxide (85% purity) was dissolved in 20 ml of methanol, and the resulting solution was added dropwise to a solution of 2.24 g (20.0 mmols) of thiophenealdehyde, 3.5 g (30.0 mmols) of chloroform and 3.30 g (30 mmols) of thiophenol in 10 ml of methanol over a period of 30 minutes at room temperature. The resulting reaction mixture was stirred at room temperature for 1 hour, and heated while refluxing for 1 hour. Most of the solvent was removed by distillation under reduced pressure, and the residue was dissolved in water. The solution was rendered acidic with hydro-chloric acid, and extracted with methylene chloride. The organic layer was dried over anhydrous magnesium sulfate and purified by silica gel column chromatography eluting with diethyl ether-hexane (1:5 by volume) to obtain 2.03 g (41% yield) of a -phenyl-thio-thiophene-2-acetic acid.
Example 10 0.69 g (30 milli atom) of sodium metal was added to 30 ml of liquid ammonia, and a catalytic amount of ferric nitrate was added to the solution followed by stirring at -40C until the blue color of the mixture disappeared. A solution of 2.52 g 1 (10.1 mmols) of cC-phenylthio-thiophene-2-acetic acid in 10 ml of diethyl ether was added dropwise to the above mixture, followed by stirring at -40C for 30 minutes. A solution of 2.80 g (19.7 mmols) of methyl iodide in 5 ml of diethyl ether was added dropwise thereto, and the reaction mixture was stirred for further 30 minutes at -40C. The cooling bath was removed and the mixture was then stirred overnight to remove ammonia. The resulting solid was then dissolved in water, and the solution was rendered acidic with hydrochlroic acid and extracted with methylene chloride. The extract was dried over anhydrous mag-nesium sulfate and the solvent was removed by distillation to obtain 2.61 g (98~ yield) of a crude product. The crude product thus obtained was then purified by silica gel column chroma-tography using a relatively short column eluting with diethyl ether-hexane (1:5 by volume) to obtain 2.55 g (98% yield) of C~-phenylthio-~ -(2-thiophene)propionic acid in a substantially pure form.
NMR (CC14)~ of Product: 1.87 (3H, s), 6.7-7.1 (8H, m), 11.85 (lH, s) Example 11 7.50 g (113.8 mmols~ of potassium hydroxide was dis-solved in 20 ml of methanol, and the solution was added dropwise to a solution of 2.24 g (20.0 mmols) of thiophenealdehyde, 4.78 ~ (40.0 mmols) of chloroform and 2.71 g (30.0 mmols) of t-butyl mexcaptan in 10 ml of methanol at room temperature over a period of 1 hour. After stirring for 16 hours at room tempera-ture, the mixture was diluted with water and washed with methylene chloride. The mixture was then rendered acidic with hydrochloric acid and extracted with methylene chloride. The extract was dried over anhydrous magnesium sulfate, concentrated 11~3684 1 and purified by silica gel column chromatography eluting with diethyl ether-hexane (1:5 by volume) to obtain 1.09 g (24% yield) Of CX-t-butylthio-~ (2-thiophene)acetic acid.
NMR (CC14) ~ of Product: 1.37 (9H, s), 4.67 (lH, s), 6.73-7.23 (3H, m), 11.37 (lH, bs).
Example 12 11.5 g (0.2 mol) of potassium hydroxide was dissolved in 70 ml of ethanol, and 6.5 g (57.6 mmols) of thiophenol was added thereto while cooling with ice and stirring. After 10 minutes, 10.8 g (38.4 mmols) of 2,2,2-trichloro-1-(4-isobutyl-phenyl)ethanol prepared as described in Reference Example 5 dissolved in 15 ml of ethanol was added to the above mixture followed by stirring at room temperature for 12 hours. The reaction mixture was rendered acidic with dilute hydrochloric acid, extracted with ethyl acetate. The organic layer was washed with a saturated aqueous solution of sodium chloride and dried over anhydrous magnesium sulfate. The solvent was removed by distillation and the resulting residue was purified by a silica gel column chromatography eluting with ethyl acetate-n-hexane (1:4 ~y volume) to obtain 8.5 g (74~ yield) of 2-phenylthio-2-(4-isobutylphenyl)acetic acid having a melting point of 92-95C
tafter recrystallized from n-hexane).
Infrared Absorption Spectrum (cm ): 3100-2500, 1690, 1280, 910, 730.
NMR (CC14) ~ of Product: 0.90 (d, J=6Hz, 6H), 1.67-2.07 (m, lH), 2.43 (d, J=6Hz, 2H), 4.70 (s, lH), 6.87-7.65 (m, 9H), 11.87 (s, lH).
Example 13 A catalytic amount of ferric chloride and 0.23 g (10 mmols) of sodium metal were added to 20 ml of liquid ammonia 1 to prepare a suspension of sodium amide. To the resulting suspension was then added a solution of 1 g (3.33 mmols) of 2-phenylthio-2-(4-isobutylphenyl)acetic acid dissolved in 12 ml of diethyl ether. After stirring the mixture at -40C for 1 hour, a solution of 0.71 g (5.0 mmols) of methyl iodide dissolved in 6 ml of diethyl ether was added to the mixture. After stirring the mixture at -40C for 3 hours, the mixture was allowed to warm slowly to room temperature and stirred for 15 minutes. The reactiOn mixture was decomposed with lN hydrochloric acid, and extracted with diethyl ether. The organic layer was washed with water and dried over anhydrous magnesium sulfate. The solvent was removed by distillation and the resulting residue was puri-fied by silica gel column chromatography eluting with ethyl acetate-n-hexane (1:4 by volume) to obtain 0.705 g (67% yield) of 2-phenylthio-2-(4-isobutylphenyl)propionic acid having a melting point of 76-79C (after recrystallized from n-hexane).
Infrared Absorption Spectrum (cm 1): 3100-2500, 1690, 1270, 920, 755, 695.
NMR Absorption Spectrum (CCl~)~ : 0.92 (d, J=6Hz, 6H), 1.77 ~s, 3Hj, 1.50-1.80 (m, lH), 2.43 (d, J=6Hz, 2H), 6.83-7.50 (m, 9H), 11.5 (broad s, lH).
Elementary Analysis:
Cal d for ClgH22O2S: C, 72.57; H, 7.05(%) Found : C, 72.42; H, 7.05(%).
~eference Example 1 330 mg of methyl 2-phenylthio-2-(3-phenoxyphenyl)-propionate obtained in Example 8 was dissolved in 2 ml of acetic acid and the solution was heated while refluxing for 1 hour in the presence of 300 mg of zinc powder. After allowing the ~q33684 1 reaction mixture to cool, it was diluted with ethyl acetate and the remaining zinc powder was removed by filtration. The fil-trate was concentrated to obtain methyl 2-(3-phenoxyphenyl)-propionate in a quantitative yield.
n26 1.5576.
NMR (CC14) ~ of Product: 1.43 (3H, d, J=7.5 Hz), 3.57 (lH, q, J=7.5 Hz), 3.63 (3H, s), 6.6-7.3 (9H, m).
~eference Exa~mple 2 .
1.11 g (3.17 mmols) of 2-phenylthio-2-(3-phenoxy-phenyl)propionic acid obtained in Example 6 was dissolved in 10 ml of acetic acid and the solution was heated while refluxing for 1 hour with stirring in the presence of 1.0 g of zinc powder.
The solid substance present in the reaction mixture was removed by filtration and washed with methylene chloride. The combined filtrate and washing was concentrated to obtain 0.86 g of a crude product which was then purified by silica gel column chromatography eluting with diethyl ether-hexane (1:5 by volume) to obtain 0.73 g (95% yield) of 2-(3-phenoxyphenyl)propionic acid. nD 1.5780.
NMR (CC14) ~ of Product: 1.48 (3H, d, J=7Hz), 3.62 (lH, q, J=7Hz), 6.6-7.6 (9H, m).
Reference Example 3 1.12 g (20 mmols) of potassium hydroxide was dissolved in 10 ml of methanol-in an argon atmosphere, and 0.6 g (5.45 mmols~ of thiophenol was added to the solution while stirring under cooling with water. After 10 minutes, a solution of 1.16 g (5 mmols) of ~ -trichloro-2-thiophenemethanol dissolved in 3 ml of methanol was added to the mixture. After lC minutes, the temperature of the mixture was gradually increased and then ~3684 1 heated under refluxing for 2 hours with vigorous stirring. The Mixture was then cooled to room temperature, and most of the solvent was removed by distillation under reduced pressure.
Diethyl ether was added to the residue and the mixture was decom-posed with dilute hydrochloric acid. The ether layer was separ-ated, washed with water, dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography eluting with ethyl acetate-n-hexane (1:4 by volume) to obtain 940 mg (76% yield) of ~-phenylthio-thiophene-2-acetic acid as a viscous oily substance.
Infrared Absorption Spectrum (cm 1) : 3060, 1715, 1587, 1485, 1440, 1416, 1253, 750, 705, 694.
NMR (CDC13) ~ : 5.03 (s, lH), 6.52-7.60 (m, 8H), 11.47 (s, lH).
Reference Example 4 2.34 g (8.85 mmols) of ~ -phenylthio-~-(2-thiophene)-propionic acid was dissolved in 20 ml of acetic acid, and 1.5 g of zinc powder was added thereto followed by heat-refluxing for 30 minutes. An additional 1.5 g of zinc powder was added thereto followed by heat-refluxing for further 1.5 hours. Most of the solvent was then removed under reduced pressure, and methylene chloride was added to the residue. The solution was then filtered through Celite to remove solid substance. The filtrate was then concentrated and purified by silica gel column chroma-tography eluting with diethyl ether-hexane (1:10 by volume) to obtain 1.28 g (92% yield) of ~ -(2-thiophene)propionic acid as a colorless oily substance.
NMR tCC14) ~ : 1.60 (3H, d, J=7Hz), 3.93 (lH, q, J=7Hz), 6.67-6.87 (2H, m), 7.07 (lH, m).
i~3684 1 Reference Example 5 .
17.7 g (0.12 mol) of chloral was dissolved in 90 ml of dichloromethane, and 11.4 g (60 mmols) of titanium tetrachloride was added to the solution in an argon atmosphere while cooling with ice and stirring. A solution of 8.05 g (60 mmols) of iso-butylbenzene dissolved in 8 ml of dichloromethane was added there-to and the temperature of the resulting mixture was increased slowly to room temperature followed by stirring for 5 hours. The reaction mixture was then again cooled with ice, decomposed with water and extracted with dichloromethane. The organic layer was washed with water, and dried over anhydrous magnesium sulfate.
Unreacted isobutylbenzene was recovered (3.6 g; Percent Recovery, 45~, Boiling Point, 65-64C/20 mmHg) to obtain 6.8 g (73~ yield based on isobutylbenzene) of 2,2,2-trichloro-1-(4-isobutyl-phenyl)ethanol having a boiling point of 115C/0.2 mmHg.
Infrared Absorption Spectrum (cm 1): 3420, 2950, 1610, 1510, 1060, 820.
NMR Absorption Spectrum (CC14) ~ : 0.93 (d, J=6.5 ~z, 6H ), 1.56-2.50 (m, lH), 2.50 (d, J=6.5Hz, 2H), 3.~8 (broad s, lH), 5.05 (s, lH), 6.97-7.47 (m, 4H).
Reference Example 6 0.3 g (0.955 mmol) of 2-phenylthio-2-(4-isobutyl-phenyl)propionic acid was dissolved in 6 ml of acetic acid, and 0.31 g (4.8 mmols) of zinc powder was added thereto followed by heating for 3 hours with stirring. The reaction was then filtered through Celite, and the filtrate was concentrated under reduced pressure. The concentrate was extracted with diethyl ether, and the organic layer was washed with water and dried over
3~ anhydrous magnesium sulfate. The solvent was then removed by 1 distillation and the residue was purified by silica gel column chromatography eluting with ethyl acetate-n-hexane (1:9 by volume) to obtain 0.136 g (69~ yield) of 2~(4-isobutylphenyl)propionic acid having a melting point of 74-76C (after recrystallized from n-hexane).
Infrared Absorption Spectrum (cm ): 3100-2600, 1720, 1230, g30, 775.
NMR Absorption Spectrum (CC14) ~ : 0.90 (d, J=6Hz, 6H), 1.60 (d, J=7Hz, 3H), 1.4-2.07 (m, lH), 2.40 (d, J=6Hz, 2H), 3.55 (q, J=7Hz, lH), 7.00 (qAB~ J 7Hz, 4H), 11.70 (s, lH).
Infrared Absorption Spectrum (cm ): 3100-2600, 1720, 1230, g30, 775.
NMR Absorption Spectrum (CC14) ~ : 0.90 (d, J=6Hz, 6H), 1.60 (d, J=7Hz, 3H), 1.4-2.07 (m, lH), 2.40 (d, J=6Hz, 2H), 3.55 (q, J=7Hz, lH), 7.00 (qAB~ J 7Hz, 4H), 11.70 (s, lH).
Claims (9)
- Claim 1 continued an alkyl- or arylsulfonyloxy group or a sulfuric acid ester residual group, in the presence of at least 2 mols of a base per mole of the 2-(arylthio or alkylthio)-2-substituted-acetic acid, to form the compound of the formula (I) wherein R4 represents a hydrogen atom and, optionally, converting the resulting compound to the compound of the formula (I) wherein R represents an alkyl group by esterification.
- 2. The process according to Claim 1, wherein said alkylat-ing is carried out at a temperature of about -40°C to room tempera-ture for about 1 to about 5 hours in the presence of a solvent.
- 3. The process according to Claim 1, wherein said alkylat-ing agent is used in an amount of about 1 to about 1.5 mol per mol of said 2-(arylthio or alkylthio)-2-substituted-acetic acid.
4. A process for preparing a 2-thio-2-substituted-alkanoic acid derivative represented by the formula (I) (I) wherein A represents (1) a substituted-phenyl group of the formula in which Y1 represents an isobutyl group or an unsubstituted- or substituted-phenoxy group wherein the substituent is a halogen atom, a trifluoromethyl group or an alkoxy group having 1 to 4 carbon atoms, or (2) a substituted-thienyl group of the formula - Claim 4 continued in which Y2 represents an alkyl group having 1 to 4 carbon atoms;
R represents an alkyl group having 1 to 4 carbon atoms; R3 represents a phenyl group, an alkylphenyl group wherein the alkyl group has 1 to 4 carbon atoms, or an alkyl group having 1 to 4 carbon atoms; and R4 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, which comprises condensing an aldehyde compound of the formula (V) A--CHO (V) wherein A is as defined above, with a haloform of the formula CHX3 wherein X represents a halogen atom and a mercaptan compound of the formula (IV) R3SH (IV) wherein R3 is as defined above, in the presence of a base to produce a 2-(arylthio or alkylthio)-2-substituted-acetic acid of the formula (III) (III) wherein A and R3 are as defined above, and reacting the resulting 2-(arylthio or alkylthio)-2-substituted-acetic acid with an alkylating agent represented by the formula (II) RZ (II) wherein R is as defined above, and Z represents a halogen atom, an alkyl- or arylsulfonyloxy group or a sulfuric acid ester residual group, in the presence of at least 2 mols of a base per mol of the 2-(arylthio or alkylthio)-2-substituted-acetic acid, to form the compound of the formula (I) wherein R4 represents a hydrogen atom and, optionally, converting the resulting compound to the compound of the formula (I) wherein R4 represents an alkyl group by esterification. - 5. The process according to Claim 4, wherein said conden-sing is conducted using about 4 to about 10 mols of a base at a temperature of about 0 to about 100°C for a period of about 1 to about 30 hours.
- 6. The process according to Claim 4, wherein said conden-sing is conducted using about 1 to about 5 mols of said haloform and about 1 to about 3 mols of said mercaptan compound, per mol of said aldehyde compound of the formula (V).
- 7. The process according to Claim 4, wherein said alkylat-ing is carried out a temperature of about -40°C to room tempera-ture for a period of about 1 to about 5 hours in the presence of a solvent.
- 8. The process according to Claim 4, wherein said alkylat-ing agent is used in an amount of about 1 to about 1.5 mol per mol of said 2-(arylthio or alkylthio)-2-substituted-acetic acid.
9. A process for preparing a 2-thio-2-isobutylphenyl-alkanoic acid derivative represented by the formula (I) (I) wherein Y1 represents an isobutyl group; R represents an alkyl group having 1 to 4 carbon atoms; R3 represents a phenyl group, an alkylphenyl group wherein the alkyl group has 1 to 4 carbon atoms; and R represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, which comprises reacting a 2,2,2-trihalo-1-(isobutylphenyl)ethanol of the formula (V') (V') - Claim 9 continued wherein Y1 is as defined above and X represents a halogen atom, with a mercaptan compound of the formula (IV) R3SH (IV) wherein R3 is as defined above, in the presence of a base, to form a 2-(arylthio or alkylthio)-2-isobutylphenylacetic acid derivative of the formula (III) (III) wherein Y1 and R3 are as defined above, and alkylating the re-sulting compound with an alkylating agent represented by the formula (II) RZ (II) wherein R is as deined above and Z represents a halogen atom, an alkyl- or arylsulfonyloxy group or a sulfuric acid ester residual group, in the presence of at least 2 mols of a base per mol or said 2-(arylthio or alkylthio)-2-isobutylphenylacetic acid derivative, to form the compound of the formula (I) wherein R4 represents a hydrogen atom and, optionally, converting the resulting compound to the compound of the formula (I) wherein R4 represents an alkyl group by esterification.
1. A process for preparing a 2-thio-2-substituted-alkanoic acid derivative represented by the formula (I) (I) wherein A represents (1) a substituted-phenyl group of the formula in which Y1 represents an isobutyl group or an unsubstituted- or substituted-phenoxy group wherein the substitutent is a halogen atom, a trifluoromethyl group or an alkoxy group having 1 to 4 carbon atoms, or (2) a substituted-thienyl group of the formula in which Y2 represents an alkyl group having 1 to 4 carbon atoms;
R represents an alkyl group having 1 to 4 carbon atoms; R3 repre-sents a phenyl group, an alkyl-phenyl group wherein the alkyl group has 1 to 4 carbon atoms, or an alkyl group having 1 to 4 carbon atoms; and R4 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, which comprises reacting a 2-(arylthio or alkylthio)-2-substituted-acetic acid of the formula (III) (III) wherein A and R3 are as defined above, with an alkylating agent represented by the formula (II) RZ (II) wherein R is as defined above and Z represents a halogen atom,
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP98271/77 | 1977-08-18 | ||
JP9827177A JPS5432437A (en) | 1977-08-18 | 1977-08-18 | 2-thio-2-(3-phenoxyphenyl)alkane-carboxylic acid derivatives and their preparation |
JP10682677A JPS5441867A (en) | 1977-09-07 | 1977-09-07 | Alpha-thio--alpha(2-thienyl)alkanoic acid derivative and its preparation |
JP106826/77 | 1977-09-07 | ||
JP123506/77 | 1977-10-17 | ||
JP12350677A JPS5459246A (en) | 1977-10-17 | 1977-10-17 | 2-thio-2-(4-isobutylphenyl) alkane acid derivatives and their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1103684A true CA1103684A (en) | 1981-06-23 |
Family
ID=27308618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA309,676A Expired CA1103684A (en) | 1977-08-18 | 1978-08-18 | Process for preparing 2-thio-2-substituted-alkanoic acid derivatives |
Country Status (4)
Country | Link |
---|---|
CA (1) | CA1103684A (en) |
DE (1) | DE2836257A1 (en) |
FR (1) | FR2400507A1 (en) |
GB (1) | GB2007220B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3700732A1 (en) * | 1987-01-13 | 1988-07-21 | Boehringer Mannheim Gmbh | NEW CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3584056A (en) * | 1967-03-13 | 1971-06-08 | Procter & Gamble | Process for preparing alkali metal alkyl thiomethyl mercaptans by reaction of alkylthiomethylmetal compounds and sulfur |
-
1978
- 1978-08-14 GB GB7833298A patent/GB2007220B/en not_active Expired
- 1978-08-18 CA CA309,676A patent/CA1103684A/en not_active Expired
- 1978-08-18 FR FR7824142A patent/FR2400507A1/en active Granted
- 1978-08-18 DE DE19782836257 patent/DE2836257A1/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
FR2400507B1 (en) | 1984-07-27 |
FR2400507A1 (en) | 1979-03-16 |
DE2836257A1 (en) | 1979-03-01 |
GB2007220A (en) | 1979-05-16 |
GB2007220B (en) | 1982-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5308865A (en) | 2-cyano-3-hydroxy-enamides | |
JP2004524358A (en) | Method for producing phenylacetic acid derivative | |
US20070072254A1 (en) | Manufacture of vitamin b6 | |
US5151545A (en) | 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents | |
CN109553518B (en) | Preparation method of substituted phenylacetic acid derivative | |
US4242519A (en) | Novel α-thio-alkanoic acid derivatives | |
EP0151702A2 (en) | Alpha-hydroxyketone acetals | |
CA1103684A (en) | Process for preparing 2-thio-2-substituted-alkanoic acid derivatives | |
US4245108A (en) | Process for preparing 2-thio-2-substituted-alkanoic acid derivatives | |
US4219659A (en) | Process for the preparation of thiophene derivatives and thiophene derivatives obtained therethrough | |
JP2574085B2 (en) | Method for producing 3-amino-2-thiophenecarboxylic acid derivative | |
JPH0770037A (en) | Production of cyanoacylcyclopropane compound and 2-cyanoacyl-4-butanolide compound used therefor | |
CA1068302A (en) | Process for the preparation of an acetonitrile derivative | |
US6235905B1 (en) | Process for preparing alkoxypyrazine derivatives | |
US4247715A (en) | 2-Alkynyl-5-indanyloxyacetic acids | |
US4577025A (en) | Method of preparing α-aromatic propionic acids and intermediates thereof | |
US4131747A (en) | Process for preparing α-substituted phenylalkanecarboxylic acid | |
US4334088A (en) | 2-Alkynyl-5-indanyloxyacetic acids | |
US4340740A (en) | Alpha-thio-alpha-aryl-substituted alkanonitrile and process for preparing alpha-aryl-substituted alkanonitrile therefrom | |
JP3777407B2 (en) | Method for producing carboxylic acid derivative | |
EP0160241B1 (en) | Process for producing an alpha-aromatic group substituted alkanoic acid derivative | |
WO2005058918A1 (en) | Novel phenyl-boronic acid derivatives and methods for the production thereof | |
US5214198A (en) | Process for the manufacture of halomaleic and halofumaric esters | |
JPH0210829B2 (en) | ||
JPH07278047A (en) | Production of aryloxypropionic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |